20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Olaparib (CAS 763113-22-0): A Key Pharmaceutical Intermediate for Targeted Cancer Therapies

In the realm of pharmaceutical development, specific chemical intermediates serve as the foundational building blocks for life-saving medications. Olaparib (CAS 763113-22-0) is one such critical intermediate, widely recognized for its role as a potent PARP inhibitor used in targeted cancer therapies.

Olaparib's significance lies in its mechanism of action: it selectively inhibits Poly(ADP-ribose) polymerase (PARP) enzymes, which are essential for repairing single-strand DNA breaks. In cancer cells with defects in other DNA repair pathways, such as those with BRCA mutations, inhibiting PARP leads to the accumulation of DNA damage and ultimately cell death. This targeted approach has revolutionized the treatment of certain cancers, including specific types of ovarian, breast, pancreatic, and prostate cancers.

As a dedicated manufacturer and supplier of Olaparib, our focus is on delivering a product of exceptional quality and purity, consistently exceeding 99%. This high standard is crucial for researchers and pharmaceutical formulators who rely on precise chemical compositions for their drug development pipelines. Whether you are a scientist investigating new therapeutic applications or a procurement manager securing raw materials, our commitment is to provide a reliable supply chain.

Sourcing Olaparib from a reputable manufacturer in China ensures access to competitive pricing and consistent product availability, whether for laboratory research or larger-scale manufacturing. We understand the rigorous demands of the pharmaceutical industry and are equipped to meet them with a product that adheres to strict quality control measures. Our chemical properties, including molecular formula (C24H23FN4O3) and molecular weight (434.47 g/mol), are thoroughly documented to support your development processes.

The therapeutic applications of Olaparib are extensive, making it a highly sought-after pharmaceutical intermediate. By choosing us as your Olaparib supplier, you gain a partner dedicated to supporting your efforts in developing innovative cancer treatments. We encourage researchers and companies to buy Olaparib from us, confident in our ability to deliver quality and reliability.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Olaparib: Mechanism, Applications, and Supply Chain for Researchers

Next: The Role of Olaparib (CAS 763113-22-0) in Advancing Cancer Research and Treatment

All Rights Reserved